Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AUDIOWOLF: A Phase II, Open-label, Efficacy Study of Daily Administration of Sodium Valproate in Patients Clinically Affected by Wolfram Syndrome Due to Monogenic Mutation.

NCT04940572 is registered in ClinicalTrials.gov with Centre d'Etude des Cellules Souches as lead sponsor.

NCT NCT04940572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04940572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AUDIOWOLF: A Phase II, Open-label, Efficacy Study of Daily Administration of Sodium Valproate in Patients Clinically Affected by Wolfram Syndrome Due to Monogenic Mutation.
Lead sponsor
Centre d'Etude des Cellules Souches
Phase
Phase 2
Overall status
Unknown status
Start date
November 26, 2021
Completion date
December 1, 2025
Enrollment
23 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

wolfram syndrome